IMVT · Immunovant Inc. Common Stock
View on chartInsiders & Stakes
| Salzmann Peter Chief Executive Officer | ▼ Sell | Open Market | 1,178,191 Shares held | 4/16/2025 | View profile |
| Frank Torti President and Vant Chair | ▲ Buy | Grant | 1,009,228 Shares held | 4/7/2026 | View profile |
| Butchko Julia G. Chief Dev. & Tech. Officer | ▼ Sell | Open Market | 440,959 Shares held | 8/21/2024 | View profile |
| Barnett Eva Renee Chief Financial Officer | ▼ Sell | Open Market | 396,774 Shares held | 4/16/2025 | View profile |
| Macias William L. Chief Medical Officer | ▼ Sell | Open Market | 357,353 Shares held | 2/19/2025 | View profile |
| Levine Mark S. Chief Legal Officer | ▼ Sell | Open Market | 319,228 Shares held | 11/20/2024 | View profile |
| Eric Venker Chief Executive Officer | ▼ Sell | Open Market | 257,075 Shares held | 10/2/2026 | View profile |
| Tiago Girao Chief Financial Officer | ▼ Sell | Open Market | 240,798 Shares held | 7/23/2026 | View profile |
| Geffner Michael Chief Medical Officer | ▼ Sell | Open Market | 217,958 Shares held | 10/22/2025 | View profile |
| Melanie Gloria Chief Operating Officer | ▼ Sell | Open Market | 217,060 Shares held | 10/7/2026 | View profile |
| Jay S. Stout Chief Technology Officer | ▼ Sell | Open Market | 201,532 Shares held | 10/7/2026 | View profile |
| Van Tuyl Christopher Chief Legal Officer | ▼ Sell | Open Market | 175,218 Shares held | 10/7/2026 | View profile |
| George Migausky V Director | ▲ Buy | Grant | 137,251 Shares held | 4/1/2025 | View profile |
| Douglas J. Hughes Director | ▲ Buy | Grant | 134,653 Shares held | 4/7/2026 | View profile |
| Atul Pande Director | ▼ Sell | Open Market | 116,731 Shares held | 8/28/2026 | View profile |
| Andrew J. Fromkin Director | ▼ Sell | Open Market | 74,382 Shares held | 5/28/2026 | View profile |
| Jake Bauer Director | ▲ Buy | Grant | 38,896 Shares held | 4/7/2026 | View profile |
| Robert Graham Susman | ▼ Sell | Open Market | 36,394 Shares held | 5/1/2026 | View profile |
Transaction History
| Jay S. Stout | ▼ Sell | Open Market | 2,213 | $71K | 10/7/2026 |
| Jay S. Stout | ▼ Sell | Open Market | 1,596 | $51K | 10/7/2026 |
| Van Tuyl Christopher | ▼ Sell | Open Market | 1,327 | $43K | 10/7/2026 |
| Melanie Gloria | ▼ Sell | Open Market | 2,241 | $72K | 10/7/2026 |
| Eric Venker | ▼ Sell | Open Market | 3,506 | $120K | 10/2/2026 |
| Eric Venker | ▲ Buy | Option Exercise | 92,187 | $1.3M | 10/1/2026 |
| Eric Venker | ▼ Sell | Other | 85,886 | $2.9M | 10/1/2026 |
| Van Tuyl Christopher | ▼ Sell | Open Market | 2,846 | $103K | 9/23/2026 |
| Atul Pande | ▲ Buy | Option Exercise | 1,500 | $13K | 8/28/2026 |
| Atul Pande | ▼ Sell | Open Market | 1,500 | $65K | 8/28/2026 |
| Melanie Gloria | ▼ Sell | Open Market | 3,056 | $135K | 8/20/2026 |
| Atul Pande | ▲ Buy | Option Exercise | 1,500 | $13K | 7/24/2026 |
| Atul Pande | ▼ Sell | Open Market | 1,500 | $60K | 7/24/2026 |
| Tiago Girao | ▼ Sell | Open Market | 6,798 | $263K | 7/23/2026 |
| Jay S. Stout | ▼ Sell | Open Market | 2,857 | $111K | 7/23/2026 |
| Jay S. Stout | ▼ Sell | Open Market | 1,906 | $75K | 7/8/2026 |
| Jay S. Stout | ▼ Sell | Open Market | 105 | $4K | 7/8/2026 |
| Melanie Gloria | ▼ Sell | Open Market | 1,930 | $76K | 7/8/2026 |
| Melanie Gloria | ▼ Sell | Open Market | 106 | $4K | 7/8/2026 |
| Van Tuyl Christopher | ▼ Sell | Open Market | 1,143 | $45K | 7/8/2026 |
| Van Tuyl Christopher | ▼ Sell | Open Market | 63 | $3K | 7/8/2026 |
| Jay S. Stout | ▼ Sell | Open Market | 1,399 | $55K | 7/8/2026 |
| Jay S. Stout | ▼ Sell | Open Market | 77 | $3K | 7/8/2026 |
| Eric Venker | ▼ Sell | Open Market | 3,092 | $119K | 7/2/2026 |
| Eric Venker | ▲ Buy | Option Exercise | 92,188 | $1.3M | 7/1/2026 |
| Eric Venker | ▼ Sell | Other | 86,629 | $3.3M | 7/1/2026 |
| Melanie Gloria | ▼ Sell | Open Market | 2,966 | $116K | 6/26/2026 |
| Jay S. Stout | ▼ Sell | Open Market | 6,723 | $262K | 6/26/2026 |
| Tiago Girao | ▲ Buy | Option Exercise | 10,000 | $159K | 6/26/2026 |
| Atul Pande | ▲ Buy | Option Exercise | 1,500 | $13K | 6/26/2026 |
| Atul Pande | ▼ Sell | Open Market | 1,500 | $57K | 6/26/2026 |
| Van Tuyl Christopher | ▼ Sell | Open Market | 2,842 | $111K | 6/26/2026 |
| Tiago Girao | ▼ Sell | Open Market | 10,000 | $385K | 6/26/2026 |
| Van Tuyl Christopher | ▲ Buy | Option Exercise | 17,824 | $271K | 6/26/2026 |
| Van Tuyl Christopher | ▼ Sell | Open Market | 14,982 | $572K | 6/26/2026 |
| Melanie Gloria | ▼ Sell | Open Market | 14,748 | $563K | 6/26/2026 |
| Jay S. Stout | ▼ Sell | Open Market | 33,277 | $1.3M | 6/26/2026 |
| Van Tuyl Christopher | ▼ Sell | Open Market | 2,634 | $93K | 6/18/2026 |
| Atul Pande | ▲ Buy | Option Exercise | 1,500 | $13K | 6/15/2026 |
| Atul Pande | ▼ Sell | Open Market | 1,500 | $51K | 6/15/2026 |
| Andrew J. Fromkin | ▲ Buy | Option Exercise | 31,668 | $158K | 5/28/2026 |
| Andrew J. Fromkin | ▲ Buy | Option Exercise | 71,492 | $568K | 5/28/2026 |
| Andrew J. Fromkin | ▼ Sell | Open Market | 11,483 | $375K | 5/28/2026 |
| Andrew J. Fromkin | ▲ Buy | Option Exercise | 77,181 | $651K | 5/28/2026 |
| Andrew J. Fromkin | ▲ Buy | Option Exercise | 16,260 | $239K | 5/28/2026 |
| Andrew J. Fromkin | ▼ Sell | Open Market | 210,468 | $7.1M | 5/28/2026 |
| Melanie Gloria | ▼ Sell | Open Market | 249 | $8K | 5/20/2026 |
| Melanie Gloria | ▼ Sell | Open Market | 1,168 | $38K | 5/20/2026 |
| Melanie Gloria | ▼ Sell | Open Market | 1,698 | $56K | 5/20/2026 |
| Atul Pande | ▲ Buy | Option Exercise | 6,000 | $51K | 5/20/2026 |
| Atul Pande | ▼ Sell | Open Market | 6,000 | $192K | 5/20/2026 |
| Robert Graham Susman | ▼ Sell | Open Market | 2,502 | $68K | 5/1/2026 |
| Tiago Girao | ▼ Sell | Open Market | 25,760 | $763K | 4/23/2026 |
| Jay S. Stout | ▼ Sell | Open Market | 2,754 | $82K | 4/23/2026 |
| Van Tuyl Christopher | ▼ Sell | Open Market | 5,165 | $128K | 4/8/2026 |
| Melanie Gloria | ▼ Sell | Open Market | 8,722 | $217K | 4/8/2026 |
| Jay S. Stout | ▼ Sell | Open Market | 8,614 | $214K | 4/8/2026 |
| Jay S. Stout | ▼ Sell | Open Market | 1,518 | $38K | 4/8/2026 |
| Atul Pande | ▲ Buy | Grant | 13,880 | $0 | 4/7/2026 |
| Jake Bauer | ▲ Buy | Grant | 13,880 | $0 | 4/7/2026 |
| Robert Graham Susman | ▲ Buy | Grant | 13,880 | $0 | 4/7/2026 |
| Melanie Gloria | ▲ Buy | Grant | 83,671 | $0 | 4/7/2026 |
| Frank Torti | ▲ Buy | Grant | 174,189 | $0 | 4/7/2026 |
| Andrew J. Fromkin | ▲ Buy | Grant | 13,880 | $0 | 4/7/2026 |
| Douglas J. Hughes | ▲ Buy | Grant | 13,880 | $0 | 4/7/2026 |
| Jay S. Stout | ▲ Buy | Grant | 66,937 | $0 | 4/7/2026 |
| Van Tuyl Christopher | ▲ Buy | Grant | 41,343 | $0 | 4/7/2026 |
| Tiago Girao | ▲ Buy | Grant | 64,968 | $0 | 4/7/2026 |
| Eric Venker | ▲ Buy | Grant | 232,252 | $0 | 4/7/2026 |
| Eric Venker | ▼ Sell | Open Market | 1,409 | $35K | 4/2/2026 |
| Eric Venker | ▼ Sell | Open Market | 12,820 | $308K | 4/2/2026 |
| Eric Venker | ▲ Buy | Option Exercise | 368,750 | $5.3M | 4/1/2026 |
| Eric Venker | ▼ Sell | Other | 334,960 | $8.4M | 4/1/2026 |
| Van Tuyl Christopher | ▼ Sell | Open Market | 2,877 | $72K | 3/18/2026 |
| Melanie Gloria | ▼ Sell | Open Market | 859 | $24K | 2/25/2026 |
| Melanie Gloria | ▼ Sell | Open Market | 942 | $27K | 2/25/2026 |
| Melanie Gloria | ▼ Sell | Open Market | 1,437 | $39K | 2/25/2026 |
| Jay S. Stout | ▼ Sell | Open Market | 1,977 | $51K | 1/21/2026 |
| Jay S. Stout | ▼ Sell | Open Market | 1,148 | $30K | 1/7/2026 |
| Jay S. Stout | ▼ Sell | Open Market | 55 | $1K | 1/7/2026 |
| Van Tuyl Christopher | ▼ Sell | Open Market | 8,529 | $228K | 12/18/2025 |
| Van Tuyl Christopher | ▼ Sell | Open Market | 2,284 | $63K | 12/18/2025 |
| Douglas J. Hughes | ▼ Sell | Open Market | 1,909 | $46K | 12/1/2025 |
| Andrew J. Fromkin | ▼ Sell | Open Market | 19,351 | $448K | 12/1/2025 |
| Andrew J. Fromkin | ▼ Sell | Open Market | 2,898 | $69K | 12/1/2025 |
| Douglas J. Hughes | ▼ Sell | Open Market | 13,091 | $303K | 12/1/2025 |
| Melanie Gloria | ▼ Sell | Open Market | 10,251 | $241K | 11/20/2025 |
| Melanie Gloria | ▼ Sell | Open Market | 2,375 | $57K | 11/20/2025 |
| Geffner Michael | ▼ Sell | Open Market | 2,595 | $49K | 10/22/2025 |
| Jay S. Stout | ▼ Sell | Open Market | 2,520 | $48K | 10/22/2025 |
| Geffner Michael | ▼ Sell | Open Market | 1,272 | $21K | 10/8/2025 |
| Jay S. Stout | ▼ Sell | Open Market | 1,585 | $26K | 10/8/2025 |
| Jay S. Stout | ▼ Sell | Open Market | 2,805 | $51K | 7/23/2025 |
| Geffner Michael | ▼ Sell | Open Market | 2,385 | $43K | 7/23/2025 |
| Geffner Michael | ▼ Sell | Open Market | 1,160 | $20K | 7/9/2025 |
| Jay S. Stout | ▼ Sell | Open Market | 1,519 | $26K | 7/9/2025 |
| Tiago Girao | ▲ Buy | Grant | 208,388 | $0 | 5/1/2025 |
| Jake Bauer | ▲ Buy | Grant | 25,016 | $0 | 5/1/2025 |
| Robert Graham Susman | ▲ Buy | Grant | 25,016 | $0 | 5/1/2025 |
| Jay S. Stout | ▼ Sell | Open Market | 1,925 | $28K | 4/23/2025 |
| Geffner Michael | ▼ Sell | Open Market | 2,349 | $35K | 4/23/2025 |
| Barnett Eva Renee | ▼ Sell | Open Market | 2,993 | $45K | 4/16/2025 |
| Salzmann Peter | ▼ Sell | Open Market | 8,321 | $124K | 4/16/2025 |
| Jay S. Stout | ▼ Sell | Open Market | 5,004 | $65K | 4/9/2025 |
| Geffner Michael | ▼ Sell | Open Market | 6,169 | $80K | 4/9/2025 |
| Barnett Eva Renee | ▼ Sell | Open Market | 7,013 | $91K | 4/9/2025 |
| Barnett Eva Renee | ▼ Sell | Open Market | 4,050 | $53K | 4/9/2025 |
| Salzmann Peter | ▼ Sell | Open Market | 28,094 | $365K | 4/9/2025 |
| Van Tuyl Christopher | ▲ Buy | Grant | 50,787 | $0 | 4/1/2025 |
| Melanie Gloria | ▲ Buy | Grant | 76,181 | $0 | 4/1/2025 |
| Jay S. Stout | ▲ Buy | Grant | 76,181 | $0 | 4/1/2025 |
| Geffner Michael | ▲ Buy | Grant | 101,574 | $0 | 4/1/2025 |
| Barnett Eva Renee | ▲ Buy | Grant | 88,878 | $0 | 4/1/2025 |
| Salzmann Peter | ▲ Buy | Grant | 265,820 | $0 | 4/1/2025 |
| Atul Pande | ▲ Buy | Grant | 16,188 | $0 | 4/1/2025 |
| Douglas J. Hughes | ▲ Buy | Grant | 16,188 | $0 | 4/1/2025 |
| Andrew J. Fromkin | ▲ Buy | Grant | 16,188 | $0 | 4/1/2025 |
| George Migausky V | ▲ Buy | Grant | 16,188 | $0 | 4/1/2025 |
| Frank Torti | ▲ Buy | Grant | 199,365 | $0 | 4/1/2025 |
| Andrew J. Fromkin | ▼ Sell | Open Market | 6,616 | $129K | 3/7/2025 |
| Andrew J. Fromkin | ▼ Sell | Open Market | 1,384 | $28K | 3/7/2025 |
| Macias William L. | ▼ Sell | Open Market | 2,055 | $43K | 2/19/2025 |
| Barnett Eva Renee | ▼ Sell | Open Market | 2,814 | $59K | 2/19/2025 |
| Salzmann Peter | ▼ Sell | Open Market | 15,439 | $322K | 2/19/2025 |
| Jay S. Stout | ▼ Sell | Open Market | 2,195 | $52K | 1/22/2025 |
| Geffner Michael | ▼ Sell | Open Market | 2,657 | $63K | 1/22/2025 |
| Macias William L. | ▼ Sell | Open Market | 1,883 | $45K | 1/15/2025 |
| Macias William L. | ▼ Sell | Open Market | 94 | $2K | 1/15/2025 |
| Macias William L. | ▼ Sell | Open Market | 387 | $9K | 1/15/2025 |
| Macias William L. | ▼ Sell | Open Market | 19 | $460 | 1/15/2025 |
| Barnett Eva Renee | ▼ Sell | Open Market | 2,189 | $52K | 1/15/2025 |
| Barnett Eva Renee | ▼ Sell | Open Market | 109 | $3K | 1/15/2025 |
| Salzmann Peter | ▼ Sell | Open Market | 8,352 | $199K | 1/15/2025 |
| Salzmann Peter | ▼ Sell | Open Market | 415 | $10K | 1/15/2025 |
| Barnett Eva Renee | ▼ Sell | Open Market | 4,105 | $99K | 1/8/2025 |
| Salzmann Peter | ▼ Sell | Open Market | 5,105 | $123K | 1/8/2025 |
| Van Tuyl Christopher | ▲ Buy | Grant | 109,956 | $0 | 12/16/2024 |
| Douglas J. Hughes | ▼ Sell | Open Market | 5,425 | $155K | 12/2/2024 |
| Atul Pande | ▼ Sell | Open Market | 7,750 | $221K | 12/2/2024 |
| Levine Mark S. | ▼ Sell | Open Market | 3,650 | $93K | 11/20/2024 |
| Macias William L. | ▼ Sell | Open Market | 3,353 | $85K | 11/20/2024 |
| Barnett Eva Renee | ▼ Sell | Open Market | 4,174 | $106K | 11/20/2024 |
| Salzmann Peter | ▼ Sell | Open Market | 16,692 | $425K | 11/20/2024 |
| Melanie Gloria | ▲ Buy | Grant | 109,956 | $0 | 11/18/2024 |
| Levine Mark S. | ▼ Sell | Open Market | 4,361 | $129K | 10/23/2024 |
| Geffner Michael | ▼ Sell | Open Market | 3,189 | $94K | 10/23/2024 |
| Jay S. Stout | ▼ Sell | Open Market | 2,740 | $81K | 10/23/2024 |
| Salzmann Peter | ▼ Sell | Open Market | 9,095 | $262K | 10/16/2024 |
| Macias William L. | ▼ Sell | Open Market | 2,627 | $76K | 10/16/2024 |
| Macias William L. | ▼ Sell | Open Market | 561 | $16K | 10/16/2024 |
| Levine Mark S. | ▼ Sell | Open Market | 2,860 | $82K | 10/16/2024 |
| Barnett Eva Renee | ▼ Sell | Open Market | 3,271 | $94K | 10/16/2024 |
| Barnett Eva Renee | ▼ Sell | Open Market | 5,162 | $153K | 10/9/2024 |
| Salzmann Peter | ▼ Sell | Open Market | 4,460 | $132K | 10/9/2024 |
| Levine Mark S. | ▼ Sell | Open Market | 3,164 | $101K | 8/21/2024 |
| Levine Mark S. | ▼ Sell | Open Market | 131 | $4K | 8/21/2024 |
| Macias William L. | ▼ Sell | Open Market | 2,907 | $93K | 8/21/2024 |
| Macias William L. | ▼ Sell | Open Market | 120 | $4K | 8/21/2024 |
| Barnett Eva Renee | ▼ Sell | Open Market | 3,619 | $115K | 8/21/2024 |
| Barnett Eva Renee | ▼ Sell | Open Market | 149 | $5K | 8/21/2024 |
| Butchko Julia G. | ▼ Sell | Open Market | 2,907 | $93K | 8/21/2024 |
| Butchko Julia G. | ▼ Sell | Open Market | 120 | $4K | 8/21/2024 |
| Salzmann Peter | ▼ Sell | Open Market | 14,470 | $461K | 8/21/2024 |
| Salzmann Peter | ▼ Sell | Open Market | 598 | $19K | 8/21/2024 |
| Levine Mark S. | ▼ Sell | Open Market | 4,015 | $111K | 7/24/2024 |
| Jay S. Stout | ▼ Sell | Open Market | 2,813 | $78K | 7/24/2024 |
| Geffner Michael | ▼ Sell | Open Market | 3,456 | $96K | 7/24/2024 |
| Salzmann Peter | ▼ Sell | Open Market | 510 | $16K | 7/17/2024 |
| Levine Mark S. | ▼ Sell | Open Market | 2,358 | $70K | 7/17/2024 |
| Levine Mark S. | ▼ Sell | Open Market | 147 | $4K | 7/17/2024 |
| Macias William L. | ▼ Sell | Open Market | 2,362 | $70K | 7/17/2024 |
| Macias William L. | ▼ Sell | Open Market | 147 | $4K | 7/17/2024 |
| Macias William L. | ▼ Sell | Open Market | 504 | $15K | 7/17/2024 |
| Macias William L. | ▼ Sell | Open Market | 31 | $947 | 7/17/2024 |
| Barnett Eva Renee | ▼ Sell | Open Market | 2,939 | $87K | 7/17/2024 |
| Barnett Eva Renee | ▼ Sell | Open Market | 184 | $6K | 7/17/2024 |
| Butchko Julia G. | ▼ Sell | Open Market | 2,698 | $80K | 7/17/2024 |
| Butchko Julia G. | ▼ Sell | Open Market | 169 | $5K | 7/17/2024 |
| Salzmann Peter | ▼ Sell | Open Market | 8,175 | $242K | 7/17/2024 |
| Barnett Eva Renee | ▼ Sell | Open Market | 4,747 | $133K | 7/9/2024 |
| Butchko Julia G. | ▼ Sell | Open Market | 1,527 | $43K | 7/9/2024 |
| Salzmann Peter | ▼ Sell | Open Market | 4,619 | $130K | 7/9/2024 |
| Barnett Eva Renee | ▼ Sell | Open Market | 4,042 | $120K | 5/22/2024 |
| Salzmann Peter | ▼ Sell | Open Market | 16,163 | $479K | 5/22/2024 |
| Butchko Julia G. | ▼ Sell | Open Market | 3,247 | $96K | 5/22/2024 |
| Macias William L. | ▼ Sell | Open Market | 3,247 | $96K | 5/22/2024 |
| Levine Mark S. | ▼ Sell | Open Market | 3,242 | $96K | 5/22/2024 |
| Geffner Michael | ▼ Sell | Open Market | 3,261 | $94K | 4/24/2024 |
| Jay S. Stout | ▼ Sell | Open Market | 7,239 | $209K | 4/24/2024 |
| Levine Mark S. | ▼ Sell | Open Market | 3,963 | $115K | 4/24/2024 |
| Macias William L. | ▼ Sell | Open Market | 79 | $2K | 4/17/2024 |
| Levine Mark S. | ▼ Sell | Open Market | 7,602 | $219K | 4/17/2024 |
| Levine Mark S. | ▼ Sell | Open Market | 2,225 | $67K | 4/17/2024 |
| Macias William L. | ▼ Sell | Open Market | 6,136 | $177K | 4/17/2024 |
| Macias William L. | ▼ Sell | Open Market | 1,796 | $54K | 4/17/2024 |
| Macias William L. | ▼ Sell | Open Market | 269 | $8K | 4/17/2024 |
| Barnett Eva Renee | ▼ Sell | Open Market | 9,479 | $273K | 4/17/2024 |
| Barnett Eva Renee | ▼ Sell | Open Market | 2,774 | $83K | 4/17/2024 |
| Butchko Julia G. | ▼ Sell | Open Market | 7,825 | $225K | 4/17/2024 |
| Butchko Julia G. | ▼ Sell | Open Market | 2,290 | $69K | 4/17/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Immunovant (IMVT) releases Q1 2027 earnings call transcript
Immunovant held its Q1 2027 earnings call and made the full transcript available through Benzinga. Management discussed recent results and provided an outlook for the coming quarters. The discussion comes as the stock is in oversold territory, which could heighten market attention to the commentary.
Immunovant (IMVT) releases Q1 2027 earnings call transcript. Immunovant held its Q1 2027 earnings call and made the full transcript available through Benzinga. Management discussed recent results and provided an outlook for the coming quarters. The discussion comes as the stock is in oversold territory, which could heighten market attention to the commentary.